title: Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.
abstract: Two recent genome-wide association studies have independently identified a prostate cancer susceptibility locus on chromosome 10q11.2. The most significant single-nucleotide polymorphism (SNP) marker reported, rs10993994, is 57 bp centromeric of the first exon of the MSMB gene, which encodes beta-microseminoprotein (prostatic secretory protein 94). In this study, a fine-mapping analysis using HapMap SNPs was conducted across a approximately 65-kb region (chr10: 51168330-51234020) flanking rs10993994 with 13 tag SNPs in 6,118 prostate cancer cases and 6,105 controls of European origin from the Cancer Genetic Markers of Susceptibility (CGEMS) project. rs10993994 remained the most strongly associated marker with prostate cancer risk [P = 8.8 x 10(-18); heterozygous odds ratio (OR) = 1.20, 95% confidence interval (CI): 1.11-1.30; homozygous OR = 1.64, 95% CI: 1.47-1.86 for the adjusted genotype test with 2 df]. In follow-up functional analyses, the T variant of rs10993994 significantly affected expression of in vitro luciferase reporter constructs. In electrophoretic mobility shift assays, the C allele of rs10993994 preferentially binds to the CREB transcription factor. Analysis of tumor cell lines with a CC or CT genotype revealed a high level of MSMB gene expression compared with cell lines with a TT genotype. These findings were specific to the alleles of rs10993994 and were not observed for other SNPs determined by sequence analysis of the proximal promoter. Together, our mapping study and functional analyses implicate regulation of expression of MSMB as a plausible mechanism accounting for the association identified at this locus. Further investigation is warranted to determine whether rs10993994 alone or in combination with additional variants contributes to prostate cancer susceptibility.
authors.affiliation: Laboratory of Experimental Immunology, Cancer and Inflammation Program, National Cancer Institute, Frederick, MD 21702, USA.
authors.forename: Hong
authors.initials: H
authors.lastname: Lou
authors.forename: Meredith
authors.initials: M
authors.lastname: Yeager
authors.forename: Hongchuan
authors.initials: H
authors.lastname: Li
authors.forename: Jesus Gonzalez
authors.initials: JG
authors.lastname: Bosquet
authors.forename: Richard B
authors.initials: RB
authors.lastname: Hayes
authors.forename: Nick
authors.initials: N
authors.lastname: Orr
authors.forename: Kai
authors.initials: K
authors.lastname: Yu
authors.forename: Amy
authors.initials: A
authors.lastname: Hutchinson
authors.forename: Kevin B
authors.initials: KB
authors.lastname: Jacobs
authors.forename: Peter
authors.initials: P
authors.lastname: Kraft
authors.forename: Sholom
authors.initials: S
authors.lastname: Wacholder
authors.forename: Nilanjan
authors.initials: N
authors.lastname: Chatterjee
authors.forename: Heather Spencer
authors.initials: HS
authors.lastname: Feigelson
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Thun
authors.forename: W Ryan
authors.initials: WR
authors.lastname: Diver
authors.forename: Demetrius
authors.initials: D
authors.lastname: Albanes
authors.forename: Jarmo
authors.initials: J
authors.lastname: Virtamo
authors.forename: Stephanie
authors.initials: S
authors.lastname: Weinstein
authors.forename: Jing
authors.initials: J
authors.lastname: Ma
authors.forename: J Michael
authors.initials: JM
authors.lastname: Gaziano
authors.forename: Meir
authors.initials: M
authors.lastname: Stampfer
authors.forename: Fredrick R
authors.initials: FR
authors.lastname: Schumacher
authors.forename: Edward
authors.initials: E
authors.lastname: Giovannucci
authors.forename: Geraldine
authors.initials: G
authors.lastname: Cancel-Tassin
authors.forename: Olivier
authors.initials: O
authors.lastname: Cussenot
authors.forename: Antoine
authors.initials: A
authors.lastname: Valeri
authors.forename: Gerald L
authors.initials: GL
authors.lastname: Andriole
authors.forename: E David
authors.initials: ED
authors.lastname: Crawford
authors.forename: Stephen K
authors.initials: SK
authors.lastname: Anderson
authors.forename: Margaret
authors.initials: M
authors.lastname: Tucker
authors.forename: Robert N
authors.initials: RN
authors.lastname: Hoover
authors.forename: Joseph F
authors.initials: JF
authors.lastname: Fraumeni
authors.forename: Gilles
authors.initials: G
authors.lastname: Thomas
authors.forename: David J
authors.initials: DJ
authors.lastname: Hunter
authors.forename: Michael
authors.initials: M
authors.lastname: Dean
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Chanock
mesh_terms: D000483:Alleles; D045744:Cell Line, Tumor; D002874:Chromosome Mapping; D002879:Chromosomes, Human, Pair 10; D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D016678:Genome; D006579:Heterozygote; D006801:Humans; D008297:Male; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D011471:Prostatic Neoplasms / Q000235:genetics*; D029584:Prostatic Secretory Proteins / Q000235:genetics* / Q000502:physiology
chemical_list: D017362:Cyclic AMP Response Element-Binding Protein; D029584:Prostatic Secretory Proteins; C043076:beta-microseminoprotein